Emergent BioSolutions Inc. (NYSE:EBS) announced today that Fuad
El-Hibri, its chairman and chief executive officer, received the Ernst &
Young Entrepreneur of the Year® 2009 Award in the Technology
category in Greater Washington. According to Ernst & Young LLP, the
award recognizes outstanding entrepreneurs who are building and leading
dynamic, growing businesses. Mr. El-Hibri was selected by an independent
panel of judges and the award was presented at a special gala event on
June 18 at the Ritz-Carlton, Tysons Corner in Virginia.
“It is a tremendous honor to receive this award considering the many
biopharmaceutical and life sciences companies in the greater Washington
region,” said Mr. El-Hibri. “I am proud of Emergent BioSolutions’
continuous growth and financial strength. These successes are firmly
anchored on the entrepreneurial spirit and commitment of our employees.
All their contributions, in pursuit of our company mission to protect
life, have made this award possible.”
Under Mr. El-Hibri’s leadership, Emergent BioSolutions has expanded its
capabilities in the development and manufacture of vaccines and
immune-related therapeutics. By strengthening its core biodefense
portfolio, which includes the only FDA-licensed vaccine against anthrax
disease, Emergent has become the premier biodefense supplier of medical
countermeasures to the U.S. government.
The Ernst & Young Entrepreneur of the Year awards program celebrates its
23rd anniversary this year and continues to honor entrepreneurs who have
demonstrated excellence in such areas as innovation, financial
performance, and personal commitment to their businesses and
communities. The program has expanded to recognize business leaders in
over 135 cities in 50 countries throughout the world.
As a Greater Washington award winner, Mr. El-Hibri is now eligible for
consideration for the Ernst & Young Entrepreneur of the Year 2009
national program. Award winners in several national categories, as well
as the overall national Ernst & Young Entrepreneur of the Year award
winner, will be announced at the annual awards gala in Palm Springs,
California on November 14, 2009. The awards are the culminating event of
the Ernst & Young Strategic Growth Forum, the nation’s most prestigious
gathering of high-growth, market-leading companies.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the
development, manufacture and commercialization of vaccines and
therapeutics that assist the body’s immune system to prevent or treat
disease.
